GCTK

19.47% 0.0608

Pre-mercato: .36 -0.013 -3.49%

Glucotrack Inc (GCTK)

Panoramica Notizia Cronologia dei prezzi Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Glucotrack Inc Stock (GCTK) Company Profile

Glucotrack Inc

Healthcare (1173)

972 (8) 675-7878

301 RT 17 NORTH, RUTHERFORD

Prossima data di guadagno

Ultimi documenti SEC

GCTK's Discussions on Twitter

Confronta GCTK con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
GCTK Glucotrack Inc	0.373	5.41M	0	-8.74M	-8.25M	-2.05
ISRG Intuitive Surgical Inc	521.96	185.91B	7.87B	2.24B	586.00M	6.22
BDX Becton Dickinson Co	226.87	65.59B	20.18B	1.71B	3.07B	5.94
ALC Alcon Inc	84.89	41.99B	9.76B	1.16B	665.00M	2.34
RMD Resmed Inc	228.69	33.57B	4.81B	1.11B	1.35B	7.55
WST West Pharmaceutical Services Inc	327.56	23.72B	2.88B	499.60M	321.60M	6.74

Glucotrack Inc Borsa (GCTK) Ultime notizie

Glucotrack Inc Azioni (GCTK) Dati Finanziari

Glucotrack Inc (GCTK)

Glucotrack Inc Stock (GCTK) Company Profile

Confronta GCTK con altri titoli

Glucotrack Inc Borsa (GCTK) Ultime notizie

Glucotrack Receives Notice from Nasdaq Regarding Bid Price Rule Compliance**Washington, D.C., December 31, 2024 – Glucotrack, Inc. (NASDAQ: GCTK) recently received notification from the Nasdaq Stock Market LLC (“Nasdaq”) concerning its bid price f - Defense World

Glucotrack inks sales agreement for $8.23M stock offering - Investing.com

Glucotrack inks sales agreement for $8.23M stock offering By Investing.com - Investing.com UK

GCTK Stock Plummets to 52-Week Low at $0.21 Amid Market Struggles - Investing.com Australia

Glucotrack Initiates Human Clinical Trials for Innovative Implantable Continuous Blood Glucose Monitor - Citybuzz

Driving Innovation In Diabetes Management: Glucotrack Begins Enrollment For Human Clinical Trials For Its Implantable Continuous Blood Glucose Monitor - Nasdaq

Glucotrack begins enrollment for first human trial of continuous blood glucose monitor - Drug Delivery Business News

Glucotrack Begins Enrollment for Long-term Implantable CGM Study - MD+DI

GlucoTrack Begins Clinical Study of Implantable Glucose Monitor - TipRanks

GLUCOTRACK ANNOUNCES START OF ENROLLMENT FOR HUMAN CLINICAL STUDY OF CONTINUOUS BLOOD GLUCOSE MONITOR - The Manila Times

Glucotrack Launches Clinical Trial for 3-Year Implantable Glucose Monitor - StockTitan

Harvard Bioscience (HBIO) Stock Surges Amid Positive Analyst Rat - GuruFocus.com

GCTK stock touches 52-week low at $0.23 amid market challenges - Investing.com Australia

GCTK stock touches 52-week low at $0.23 amid market challenges By Investing.com - Investing.com South Africa

U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.11% - MSN

U.S. shares mixed at close of trade; Dow Jones Industrial Average up 0.11% - MSN

Glucotrack enters material agreements following public offering - Investing.com India

Glucotrack enters material agreements following public offering By Investing.com - Investing.com UK

Glucotrack announces pricing of $10M public offering - MSN

West Pharmaceutical Services (WST) Stock Drops Amid Sector Downt - GuruFocus.com

GlucoTrack Inc. (GCTK) Quarterly 10-Q Report - Quartzy

Glucotrack, Inc. Announces Closing of $10.0 Million Public Offering and Concurrent Private Placement Converting $4.0 in Outstanding Debt - The Manila Times

GlucoTrack Completes Funding to Enhance Financial Stability - TipRanks

Knight Therapeutics Announces Health Canada Approval for JORNAY PM™ to Treat Attention-Deficit Hyperactivity Disorder (ADHD) - The Manila Times

Glucotrack Secures $10M Through Public Offering, Converts $4M Debt to Equity | GCTK Stock News - StockTitan

STXS Stock Drops 5% Despite Strong Buy Ratings from Analysts - GuruFocus.com

Glucotrack announces $10 million public offering By Investing.com - Investing.com Canada

GCTK stock touches 52-week low at $0.42 amid market fluctuations - Investing.com Australia

500: Something went wrong - Investing.com Canada

S&P 500 Tops 6,000; Rumble Shares Slide After Q3 Results - Benzinga

Dow Jumps Over 150 Points; CyberArk Posts Upbeat Earnings - Benzinga

U.S. Stock market: Syros Pharmaceuticals(−86.21%), GlucoTrack(−77.70%) and others among the most volatile stocks during mid day trading - Business Upturn

U.S. Stock market: Syros Pharmaceuticals surges by 680.00% while Spirit Airlines rises by 184.96% in early trading - Business Upturn

US Stocks Mixed; Inflation Rate Increases In October - Benzinga

GlucoTrack prices 7.2M shares at $1.39 in public offering - TipRanks

Glucotrack announces $10 million public offering - Investing.com

Glucotrack, Inc. Announces Pricing of $10.0 Million Public Offering - The Manila Times

Fogo de Chão Launches Pro-Athlete 'Meat & Greet” Event Series With National Sports Teams - The Manila Times

Glucotrack (GCTK) Launches $10M Public Offering, Plans Note Conversion Deal | GCTK Stock News - StockTitan

Harvard Bioscience (HBIO) Stock Dips Amid Market Volatility - GuruFocus.com

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.65% - MSN

U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.66% - MSN

AtriCure (ATRC) Stock Surges Over 5% Amid Market Volatility - GuruFocus.com

United States shares lower at close of trade; Dow Jones Industrial Average down 0.67% - MSN

GlucoTrack (NASDAQ:GCTK) to Present Continuous Blood Glucose Monitor at 2024 BioFuture Meeting** - Defense World

Say Goodbye To Finger Pricks! Glucotrack($GCTK)’s Long-Lasting Glucose Monitor Is Here - MSN

GCTKGlucoTrack, Inc. Latest Stock News & Market Updates - StockTitan

GlucoTrack to Unveil Implantable Glucose Monitor at BioFuture - TipRanks

GLUCOTRACK TO PRESENT AT 2024 BIOFUTURE CONFERENCE - The Manila Times

Glucotrack Inc Azioni (GCTK) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a GCTK